Docetaxel Non-Squamous Non-Small Cell Lung Cancer Trial
NCT07821684 is a phase 3 trial in non-squamous NSCLC; we pair it with docetaxel potency in ChEMBL, 1628 registered trials and EGFR dependency in DepMap.
BioQ Blog
Every BioQ post about ChEMBL pChEMBL: real search results, sources and the query to repeat it.
NCT07821684 is a phase 3 trial in non-squamous NSCLC; we pair it with docetaxel potency in ChEMBL, 1628 registered trials and EGFR dependency in DepMap.
Trial watch on NCT07899398, a phase 2 zanubrutinib study in CLL, with ChEMBL potency and ClinicalTrials.gov counts for the drug as of 2026-11-13.
NCT07905456 is a PHASE2 gingivitis trial starting 2026-12-01; we checked chlorhexidine in ChEMBL (104 targets) and ClinicalTrials.gov (101 studies).
NCT07916844 tests hepatic arterial infusion chemotherapy versus capecitabine in resected biliary tract cancer; ChEMBL and 1231 oxaliplatin studies.
ROS1 dependency and drugs from one query: 0 of 1178 DepMap lines dependent, 5 drugs in ChEMBL and Open Targets, 711 disease links, as of 2026-11-06.
NCT07895017 tests avatrombopag around CAR T-cell therapy; BioQ adds ChEMBL potency, 38 registered avatrombopag trials and compound identity, as of 2026-11-06.